Molecular structure from independently sourced SMILES

Erlotinib 2D structure

Role
Drug
Mechanism class
EGFR TKI
Aliases
tarceva
InChIKey
AAKJLRGGTJKAMG-UHFFFAOYSA-N
Structure checked
2026-10-08
Molecular formula
C22H23N3O4
Structure source
PubChem
PubChem CID
176870
InChI Key
AAKJLRGGTJKAMG-UHFFFAOYSA-N

Read the two structures

Follow the bonds from erlotinib’s rings into its substituents and terminal groups, and inspect whether gefitinib has the same connections. Drawings can rotate or arrange the same motif differently; compare atoms and bond sequence rather than screen position.

Carbon triple bond C≡CFluorine atomsChlorine atoms
Differences measured by the selected structure queries
ObservationErlotinibGefitinib
Carbon triple bond C≡C10
Fluorine atoms01
Chlorine atoms01

Connect the structural observations with the fingerprint result

Gefitinib has one highlighted fluorine and one chlorine. Erlotinib has neither of these query matches and instead has one carbon triple-bond C≡C match. Read the coloured regions with the counts to distinguish the selected substituents concretely. [Erlotinib] · [Gefitinib]

There are 31 shared set bits across a union of 76, giving 0.408. The selected substituents differ while other encoded environments overlap. This is a whole-structure fingerprint calculation, not a score comparing only halogens and the triple bond.

Visual resemblance is a useful observation, but this calculation neither computes a maximum common substructure nor establishes an identical scaffold. Fingerprint overlap and a shared-scaffold claim require different evidence.

Calculated structural similarity: 0.408 · Morgan radius 2 / 2048 bits · Tanimoto

Calculation: 31 / (47 + 60 − 31) = 31 / 76 ≈ 0.408. Set-bit counts are not counts of unique atoms or functional groups.

Query definitions and reproducibility
  • Carbon triple bond C≡C: C#C
  • Fluorine atoms: [F]
  • Chlorine atoms: [Cl]

RDKit 2025.03.4 · Matches with identical atom sets are counted once. Colours mark atoms and bonds matching selected queries, not a proven shared scaffold or synthesis route.

  1. Read elemental composition from the formulas.
  2. Trace ring and substituent connections in each drawing.
  3. Compare your observations with the fingerprint score calculated under identical settings.
  4. Check stereochemistry and the complete InChIKey in the source records.

The score is fingerprint overlap, not a percentage of efficacy or safety. RDKit

Structure-source check: 2026-10-08 / 2026-10-08 · Editorial update and calculation check: 2026-10-16

Download source structures, queries and bit counts for this comparison (JSON)

StructureMoa editorial · source review 2026-10-08

Molecular identity

Erlotinib: independently retrieved PubChem CID 176870, formula C22H23N3O4.

How to compare

Follow the bonds from erlotinib’s rings into its substituents and terminal groups, and inspect whether gefitinib has the same connections. Drawings can rotate or arrange the same motif differently; compare atoms and bond sequence rather than screen position.

Interpretation limits

The Morgan/Tanimoto score measures fingerprint overlap. It does not establish efficacy, safety, clinical superiority or full stereochemical identity.

SMILES

COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC

Tags

EGFR1st-gen

Related compounds

Comparisons · briefs

External IDs · BioMoa

StructureMoa is a chemical-structure exploration tool. Structural similarity, clustering, and SAR relationships are intended for research exploration and do not establish shared potency, selectivity, safety, efficacy, or clinical performance.

Editorial responsibility and corrections

Operated and edited by the independent StructureMoa project. Explanations use AI assistance; structural identity and similarity are checked against source records and calculation tests. Molecular data and clinical or regulatory evidence have separate review scopes.

Source structures
PubChem · CID / SMILES / InChIKey
Calculations and automated checks
RDKit · Morgan / SMARTS
Disclosed specialist review
No separate external specialist review is disclosed. Passing automated tests is not specialist review of clinical claims.

For a correction, include the page URL, molecule name or CID, the field in question and a supporting source. Corrections are checked against sources, and the affected editorial update date is changed when a correction is published. [email protected]